novartis europharm limited - indacaterol, mometasone furoate - astma - drogy obštrukčnej choroby dýchacích ciest, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
Európska únia -
slovenčina -
EMA (European Medicines Agency)